336 related articles for article (PubMed ID: 19302956)
1. Expression of immunoreactivity and genetic mutation in eosinophilic and ciliated metaplastic changes of endometrial glandular and stromal breakdown: cytodiagnostic implications.
Shimizu K; Norimatsu Y; Kobayashi TK; Sakurai M; Ogura S; Yoshizawa A; Miyamoto T; Miyake Y; Aratake Y; Sakaguchi T; Ohno E
Ann Diagn Pathol; 2009 Apr; 13(2):89-95. PubMed ID: 19302956
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic value of endometrium associated with papillary metaplastic changes in endometrial cytopathology.
Shimizu K; Norimatsu Y; Kobayashi TK; Sakurai M; Ogura S; Yoshizawa A; Sakurai T; Miyamoto T; Miyake Y; Aratake Y; Sakaguchi T; Ohno E
Diagn Cytopathol; 2009 Jul; 37(7):487-91. PubMed ID: 19263487
[TBL] [Abstract][Full Text] [Related]
3. Expression of immunoreactivity of nuclear findings by p53 and cyclin a in endometrial cytology: Comparison with endometrial glandular and stromal breakdown and endometrioid adenocarcinoma grade 1.
Norimatsu Y; Ohsaki H; Yanoh K; Kawanishi N; Kobayashi TK
Diagn Cytopathol; 2013 Apr; 41(4):303-7. PubMed ID: 21954041
[TBL] [Abstract][Full Text] [Related]
4. Endometrial glandular and stromal breakdown, part 3: cytomorphology of "condensed cluster of stromal cells".
Norimatsu Y; Yuminamochi T; Shigematsu Y; Yanoh K; Ikemoto R; Masuno H; Murakami M; Kobayashi TK
Diagn Cytopathol; 2009 Dec; 37(12):891-6. PubMed ID: 19582808
[TBL] [Abstract][Full Text] [Related]
5. Expression of cyclin A in endometrial adenocarcinoma and its correlation with proliferative activity and clinicopathological variables.
Kyushima N; Watanabe J; Hata H; Jobo T; Kameya T; Kuramoto H
J Cancer Res Clin Oncol; 2002 Jun; 128(6):307-12. PubMed ID: 12073048
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic utility of notch-1 immunocytochemistry in endometrial cytology.
Mori M; Miyamoto T; Ohno S; Miyake Y; Sakaguchi T; Ohno E
Acta Cytol; 2012; 56(2):166-70. PubMed ID: 22378079
[TBL] [Abstract][Full Text] [Related]
7. p53 Immunostaining guided laser capture microdissection (p53-LCM) defines the presence of p53 gene mutations in focal regions of primary prostate cancer positive for p53 protein.
Griewe GL; Dean RC; Zhang W; Young D; Sesterhenn IA; Shanmugam N; McLeod DG; Moul JW; Srivastava S
Prostate Cancer Prostatic Dis; 2003; 6(4):281-5. PubMed ID: 14663467
[TBL] [Abstract][Full Text] [Related]
8. Significance of progesterone receptor-A and -B expressions in endometrial adenocarcinoma.
Miyamoto T; Watanabe J; Hata H; Jobo T; Kawaguchi M; Hattori M; Saito M; Kuramoto H
J Steroid Biochem Mol Biol; 2004 Oct; 92(3):111-8. PubMed ID: 15555905
[TBL] [Abstract][Full Text] [Related]
9. Utility of thin-layer preparations in the endometrial cytology: evaluation of benign endometrial lesions.
Norimatsu Y; Kouda H; Kobayashi TK; Moriya T; Yanoh K; Tsukayama C; Miyake Y; Ohno E
Ann Diagn Pathol; 2008 Apr; 12(2):103-11. PubMed ID: 18325470
[TBL] [Abstract][Full Text] [Related]
10. A significance of immunohistochemical determination of steroid receptors, cell proliferation factor Ki-67 and protein p53 in endometrial carcinoma.
Oreskovic S; Babic D; Kalafatic D; Barisic D; Beketic-Oreskovic L
Gynecol Oncol; 2004 Apr; 93(1):34-40. PubMed ID: 15047211
[TBL] [Abstract][Full Text] [Related]
11. Endometrial glandular and stromal breakdown, part 2: cytomorphology of papillary metaplastic changes.
Norimatsu Y; Shimizu K; Kobayashi TK; Moriya T; Kaku T; Tsukayama C; Miyake Y; Ohno E
Diagn Cytopathol; 2006 Oct; 34(10):665-9. PubMed ID: 16955472
[TBL] [Abstract][Full Text] [Related]
12. Cutaneous hidradenocarcinoma: a clinicopathological, immunohistochemical, and molecular biologic study of 14 cases, including Her2/neu gene expression/amplification, TP53 gene mutation analysis, and t(11;19) translocation.
Kazakov DV; Ivan D; Kutzner H; Spagnolo DV; Grossmann P; Vanecek T; Sima R; Kacerovska D; Shelekhova KV; Denisjuk N; Hillen U; Kuroda N; Mukensnabl P; Danis D; Michal M
Am J Dermatopathol; 2009 May; 31(3):236-47. PubMed ID: 19384064
[TBL] [Abstract][Full Text] [Related]
13. p53 alteration independently predicts poor outcomes in patients with endometrial cancer: a clinicopathologic study of 131 cases and literature review.
Lee EJ; Kim TJ; Kim DS; Choi CH; Lee JW; Lee JH; Bae DS; Kim BG
Gynecol Oncol; 2010 Mar; 116(3):533-8. PubMed ID: 20006376
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical staining for Ki-67 antigen, carcinoembryonic antigen, and p53 in the differential diagnosis of glandular lesions of the cervix.
Cina SJ; Richardson MS; Austin RM; Kurman RJ
Mod Pathol; 1997 Mar; 10(3):176-80. PubMed ID: 9071723
[TBL] [Abstract][Full Text] [Related]
15. p53 interference and growth inhibition in p53-mutant and overexpressing endometrial cancer cell lines.
Janicek MF; Angioli R; Unal AD; Sevin BU; Madrigal M; Estape R; Averette HE
Gynecol Oncol; 1997 Jul; 66(1):94-102. PubMed ID: 9234928
[TBL] [Abstract][Full Text] [Related]
16. Nuclear features in endometrial cytology: comparison of endometrial glandular and stromal breakdown and endometrioid adenocarcinoma grade 1.
Norimatsu Y; Shigematsu Y; Sakamoto S; Ohsaki H; Yanoh K; Kawanishi N; Kobayashi TK
Diagn Cytopathol; 2012 Dec; 40(12):1077-82. PubMed ID: 22241733
[TBL] [Abstract][Full Text] [Related]
17. Endometrial glandular dysplasia with frequent p53 gene mutation: a genetic evidence supporting its precancer nature for endometrial serous carcinoma.
Jia L; Liu Y; Yi X; Miron A; Crum CP; Kong B; Zheng W
Clin Cancer Res; 2008 Apr; 14(8):2263-9. PubMed ID: 18369088
[TBL] [Abstract][Full Text] [Related]
18. Utility of thin-layer preparations in endometrial cytology: immunocytochemical expression of PTEN, beta-catenin and p53 for benign endometrial lesions.
Norimatsu Y; Miyamoto T; Kobayashi TK; Oda T; Moriya T; Yanoh K; Miyake Y; Ohno E
Diagn Cytopathol; 2008 Apr; 36(4):216-23. PubMed ID: 18335551
[TBL] [Abstract][Full Text] [Related]
19. Cytodiagnosis of endometrial carcinoma and hyperplasia on imprint smears with additional immunocytochemistry using Ki-67 and p53 biomarkers.
Apostolou G; Apostolou N; Nikolaidou C; Kavantzas N; Patsouris E; Athanassiadou P
Cytopathology; 2014 Apr; 25(2):86-94. PubMed ID: 24118263
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical study of Ki-67 and DNA topoisomerase II in human endometrium.
Ito K; Sasano H; Yabuki N; Matsunaga G; Sato S; Kikuchi A; Yajima A; Nagura H
Mod Pathol; 1997 Apr; 10(4):289-94. PubMed ID: 9110289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
